Bausch & Lomb (BLCO) EBIT Growth (1y) (2022 - 2026)
Powered by 
Analysis
Bausch & Lomb (BLCO) EBIT Growth (1y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 16.18% |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 854.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 854.55% |
| Mar 31, 2026 | 139.76% |
| Dec 31, 2025 | 28.74% |
| Sep 30, 2025 | 120.93% |
| Jun 30, 2025 | -142.31% |
| Mar 31, 2025 | -1,483.33% |
| Dec 31, 2024 | 77.55% |
| Sep 30, 2024 | 7.50% |
| Jun 30, 2024 | -39.53% |
| Mar 31, 2024 | 400.00% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | -13.04% |
| Jun 30, 2023 | -23.21% |
| Mar 31, 2023 | -103.70% |
| Dec 31, 2022 | -44.57% |
| Sep 30, 2022 | -51.06% |
| Jun 30, 2022 | -3.45% |
| Mar 31, 2022 | -36.47% |